Brazil’s Anvisa says Janssen files for emergency use of its COVID-19 shot

RIO DE JANEIRO (Reuters) – Brazil’s federal health regulator Anvisa said on Wednesday that Janssen had filed for emergency use authority for its COVID-19 vaccine developed by Johnson & Johnson.

(Reporting by Pedro Fonseca; Editing by Chris Reese)